| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |